SARS-CoV-2 infects human GnRH neurons and tanycytes, disrupting hypothalamic-pituitary hormonal axes
Florent Sauvé(Inserm), Vincent Prévot(Centre Hospitalier Universitaire de Lille), Helge Müller‐Fielitz(University of Lübeck), Julien Poissy(Centre National de la Recherche Scientifique), Rubén Nogueiras(Xunta de Galicia), Asís Palazón(Ikerbasque), Gaëtan Ternier(Inserm), Cristina Iglesias(Universidade de Santiago de Compostela), María Mercado-Gómez(CIC bioGUNE), Sowmyalakshmí Rasika(Inserm), Daniela Fernandois(Inserm), June Ereño‐Orbea(Ikerbasque), Ariane Sharif(Inserm), Romain Perbet, Virginie Mattot(Inserm), V. Florent(Inserm), Sophie Catteau-Jonard(Inserm), François Trottein(Centre National de la Recherche Scientifique), Erik Hrabovszky(HUN-REN Institute of Experimental Medicine), Konstantina Chachlaki(Inserm), Florence Pasquier, Julie Dam(Centre National de la Recherche Scientifique), Paolo Giacobini(University of Turin), Erika Cecon(Centre National de la Recherche Scientifique), Ralf Jockers(Inserm), Julie Dewisme(Inserm), Laurent Storme(Université de Lille), Maria Luz Martínez‐Chantar(Instituto de Salud Carlos III), Caio Fernando Ferreira Coêlho(Inserm), Sreekala S. Nampoothiri(Inserm), Ludovica Cotellessa(Inserm), Thibaud Lebouvier(Inserm), Marc Baroncini(Inserm), Claude‐Alain Maurage(Centre Hospitalier Universitaire de Lille), Pascal Pigny(Centre Hospitalier Universitaire de Lille), Markus Schwaninger(Heidelberg University)
Cited by 2
Related Papers
Colonic Biopsies to Assess the Neuropathology of Parkinson's Disease and Its Relationship with Symptoms
|PLoS ONE|2010|425
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study
|Intensive Care Medicine|2021|420
The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage
|Journal of Neuroscience|2008|410
Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion
|Nature Communications|2016|390
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
|Nature Medicine|2021|364